Longeveron, Inc. (LGVN)
0.8624
0.00 (0.00%)
USD |
NASDAQ |
Apr 30, 11:42
Longeveron Market Cap : 25.25M for April 30, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Acadia Healthcare Co., Inc. | 2.162B |
| Charles River Laboratories International, Inc. | 8.128B |
| BioRestorative Therapies, Inc. | 5.577M |
| Fate Therapeutics, Inc. | 145.91M |
| CytomX Therapeutics, Inc. | 866.87M |
Market Cap Related Metrics
| PS Ratio | 12.81 |
| Price to Book Value | 4.450 |
| Price | 0.8624 |
| Earnings Yield | -150.8% |